Flucloxacillin in the treatment of infectious conditions in children
- 1 January 1975
- journal article
- Published by Taylor & Francis in Current Medical Research and Opinion
- Vol. 3 (2) , 77-82
- https://doi.org/10.1185/03007997509113651
Abstract
A multi-centre study was carried out in 107 children with skin and soft-tissue infections (46) or upper respiratory tract infections (61) to assess the effectiveness of flucloxacillin (125 mg. q.d.s. for 5 days). Swabs were taken from the lesion sites before and after treatment for bacteriological assessment and sensitivity of the isolated organisms. The clinical success rate achieved was 93% in skin and soft-tissue infections and 94% in upper respiratory tract infections and these results correlate closely with the bacteriological findings. The main causative organism in the skin and soft-tissue infections was Staph, aureus which was resistant to benzyl penicillin and to ampicillin in all but 2 cases. All strains proved sensitive to flucloxacillin. Minimal side-effects were reported and the syrup presentation was well accepted.Keywords
This publication has 7 references indexed in Scilit:
- Flucloxacillin: A new semisynthetic isoxazolyl penicillinClinical Pharmacology & Therapeutics, 1972
- Flucloxacillin, a New Isoxazolyl Penicillin, Compared with Oxacillin, Cloxacillin, and DicloxacillinBMJ, 1970
- ANTIBIOTICS IN SURGICAL TREATMENT OF SEPTIC LESIONSThe Lancet, 1970
- Isoxazolyl Penicillins and PenicillinaseNature, 1962
- The Newer PenicillinsAnnals of Internal Medicine, 1962
- Sensitivity of Staphylococcus Pyogenes to Benzylpenicillin and BRL 1241BMJ, 1960
- INFECTION BY PENICILLIN-RESISTANT STAPHYLOCOCCIThe Lancet, 1948